Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE: 002287)

Tibet Cheezheng Tibetan Medicine Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	315.88	403.43	437.57	666.63	1,831	1,347
Short-Term Investments	-	-	224.65	107.74	-	-
Trading Asset Securities	3,037	1,963	1,539	1,184	-	32.28
Cash & Short-Term Investments	3,353	2,366	2,202	1,958	1,831	1,379
Cash Growth	47.52%	7.49%	12.42%	6.98%	32.75%	63.83%
Accounts Receivable	729.21	604.86	825.39	606.61	1,024	678.3
Other Receivables	10.42	18.34	10.03	212.89	10.83	10.32
Receivables	739.63	623.19	835.42	819.49	1,035	688.62
Inventory	180.12	156.33	127.77	118.5	94.75	61.99
Prepaid Expenses	-	1.11	6.88	1.99	2.31	1.32
Other Current Assets	33.4	47.25	20.83	38.07	9.68	4.4
Total Current Assets	4,306	3,194	3,192	2,936	2,972	2,135
Property, Plant & Equipment	1,663	1,647	1,144	821.35	579.11	545.72
Long-Term Investments	114.25	1,043	1,116	1,357	534.28	225.15
Other Intangible Assets	331.36	351.62	374.81	399.33	176.2	45.75
Long-Term Deferred Tax Assets	37.38	39.39	30.59	26.68	26.7	8.84
Long-Term Deferred Charges	4.18	4.95	3.29	5.25	0.15	0.08
Other Long-Term Assets	73.49	17.68	26.33	21.28	173.54	23.21
Total Assets	6,530	6,298	5,888	5,568	4,462	2,984
Accounts Payable	196.67	266.23	93.47	184	52.21	20.19
Accrued Expenses	61.64	352.86	330.7	297.27	254.47	233.88
Short-Term Debt	753.78	451.52	701.73	501.81	300.16	300.19
Current Portion of Long-Term Debt	66.56	9.02	54.11	103.93	6.2	-
Current Portion of Leases	-	6.39	6.47	5.07	-	-
Current Income Taxes Payable	51.54	55.56	25.9	9.83	11.2	9.77
Current Unearned Revenue	84.92	73.89	102.16	110.11	74.45	37.5
Other Current Liabilities	149.41	29.74	45.59	95.96	65.75	52.6
Total Current Liabilities	1,365	1,245	1,360	1,308	764.44	654.13
Long-Term Debt	1,030	1,061	929.47	836.48	901.33	-
Long-Term Leases	4.35	7	4.91	4.94	-	-
Long-Term Unearned Revenue	188.07	191.3	167.04	154.66	159.27	67.78
Long-Term Deferred Tax Liabilities	29.27	20.94	36.39	40.71	1.95	0.29
Other Long-Term Liabilities	2.6	2.6	2.6	2.6	-	-
Total Liabilities	2,619	2,528	2,501	2,347	1,827	722.2
Common Stock	530.17	530.19	530.22	530.3	530.34	530.18
Additional Paid-In Capital	477.79	477.25	476.33	480.44	474.26	457.89
Retained Earnings	2,715	2,576	2,202	2,042	1,506	1,288
Treasury Stock	-	-0.48	-8.68	-16.97	-25.28	-32.11
Comprehensive Income & Other	136.93	137.25	136.4	133.14	133.33	1.23
Total Common Equity	3,860	3,720	3,336	3,169	2,619	2,246
Minority Interest	50.86	49.82	51.64	51.35	16.43	16.38
Shareholders' Equity	3,911	3,770	3,388	3,220	2,635	2,262
Total Liabilities & Equity	6,530	6,298	5,888	5,568	4,462	2,984
Total Debt	1,855	1,535	1,697	1,452	1,208	300.19
Net Cash (Debt)	1,498	831.28	504.82	506.11	622.94	1,079
Net Cash Growth	884.89%	64.67%	-0.26%	-18.75%	-42.26%	28.17%
Net Cash Per Share	2.83	1.57	0.95	0.96	1.18	2.04
Filing Date Shares Outstanding	530.17	530.19	529.64	528.63	528.03	527.84
Total Common Shares Outstanding	530.17	530.19	529.64	528.63	528.03	527.8
Working Capital	2,942	1,949	1,832	1,628	2,208	1,481
Book Value Per Share	7.28	7.02	6.30	5.99	4.96	4.25
Tangible Book Value	3,529	3,369	2,961	2,770	2,443	2,200
Tangible Book Value Per Share	6.66	6.35	5.59	5.24	4.63	4.17
Buildings	-	1,309	705.16	671.59	553.95	550.95
Machinery	-	328.81	190.32	181.58	128.32	116.66
Construction In Progress	-	302.75	533.08	212.04	70.57	20.72

Source: S&P Capital IQ. Standard template. Financial Sources.